abstract |
The invention relates to activation of apoptosis bynmeans of interference with the function of snRNPs and hnRNP-likencompounds. n Also the invention relates to anti-tumor therapies withncompounds, which negatively interfere with snRNPs and hnRNP-likencompounds leading to induction of apoptosis, resultingnin the elimination of tumor cells. n Also the invention relates to therapies for diseasesnrelated to aberrant apoptosis induction, such as auto-immunendiseases. |